
Dr. Carbone will present during AAP 2021 about managing autism in pediatric practices.

Episode 4 of Crisis Point asks the question you've been waiting for, "What is blueprint to resolving the obesity crisis?"

The treatment is the first FDA approved orally-administered inhibitor of the complement C5a receptor.

Prior to the investigation, peanut allergy was often linked to high rates of anaphylaxis, with its prevalence in children and adolescents surpassing that found in adult patients.

The long-term study from Denmark also found a strong association between gender and loss of asthma control, among other factors.

The most severe outcomes occurred in patients with a history of unhealthy alcohol use.

Data show 5 of 20 patients with history of MBS in the study experienced the primary composite outcome of IMV and/or death by day 7.

Gastrointestinal symptoms were significantly linked to severe symptoms of depression and anxiety.

Differences in CV risk factors persisted between Black participants and White participants and may be due to social determinants of health.

Dr. Fasipe shares her in-person experience viewing Phillip Okwo's Life Interrupted production about living with sickle cell disease.

Investigators from Egypt recorded a high prevalence of stress, anxiety, and depression in patients with vitiligo.

Relapse occurred in 39% of the maintenance group, compared to 56% in the discontinuation group.

Investigators call for pollen monitoring that provides free, continuous, real‐time pollen data representative for any given region.

Factors associated with decreased receipt of ophthalmic telehealth care included older age, male sex, and patients with an educational level of high school or less.

Serious infections occurred in less than 2% of patients treated with the medication during the duration of the 52-week trial.

Delgocitinib is the first and only topical JAK/STAT pathway inhibitor in Japan, and recent data suggests it is effective in the management of atopic dermatitis.

Tramadol is examined alongside codeine to determine if it puts patients at a higher risk of adverse cardiovascular events.

Dr. Lawrence Eichenfield and Dr. David Rosmarin speak to the efficacy of topical ruxolitinib displayed in several trials involving patients with atopic dermatitis and vitiligo.

An unplanned pregnancy can translate into a multitude of health factors and risks for both the mother and the baby.

Investigators also found that patients with alopecia areata were also had significant inflammatory immune injury and vitamin D deficiency when compared to healthy subjects.

Diabetes progression included greater likelihood of insulin treatment initiation, hyperglycemia, glycemic complications, and glucose-lowering prescriptions.

Just 7% of patients in the BPA group suffered a recurrent CDI episode within 14-56 days of initiating treatment.

Investigators noted the relationship of reading performance with visual acuity supports the validity of reading performance as end point in clinical trials.

Taste scores were significantly correlated with depression scores for both patients with irritable bowel syndrome and functional constipation.

The ongoing PIANO registry is designed to keep real time data on the outcomes of pregnant patients with IBD.

Dr. Paller speaks of the AD-GAP study, which shared insights on moderate to severe atopic dermatitis from patients, caregivers, and independent physicians.

Episode 3 of Crisis Point examines the regional differences in obesity, from issues with nutrition and food insecurity to the use of the phrase "food desert".

Investigators also reported an increase in individualized FeNO associated with young female patients.

Data show SGLT2 inhibitor therapy, in comparison to GLP-1 RA therapy, was associated with slightly lower risk for myocardial infarction (MI) or stroke in patients with CVD.

Investigators incorporated a myriad of studies detailing the anxiety and depression associated with the disease, and offered new insights into the concerns of patients and caregivers.